Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis (P3-5.010)
Key Points
This research aims to assess the safety and efficacy of direct oral anticoagulants compared to warfarin for cerebral venous thrombosis.
Conducted a systematic review and meta-analysis of existing studies comparing DOACs and warfarin.
Included various studies evaluating treatment outcomes for CVT using DOACs or warfarin.
DOACs demonstrated comparable efficacy to warfarin for treating CVT with a lower incidence of major bleeding events.
Findings suggest that DOACs are potentially safer, making them a viable alternative to warfarin for CVT treatment.
Abstract
To compare the safety and efficacy of direct oral anticoagulants (DOACs) versus warfarin for the treatment of Cerebral Venous Thrombosis (CVT).
Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis (P3-5.010) | Synapse